- Approximately 6,000 individuals in England are diagnosed with multiple myeloma annually
- This form of bone cancer leads to fragile bones and blurred vision
NHS funding authorities have reversed their decision to not fund a life-extending treatment for bone marrow cancer patients.
The treatment, which involves a combination of three medicines, will now be available to individuals diagnosed with multiple myeloma, a type of cancer affecting the soft tissue inside bones.
This condition leads to fragile bones that are prone to fractures, as well as blurred vision, dizziness, and excessive thirst caused by elevated levels of calcium in the bloodstream.
Multiple myeloma, a currently incurable disease, affects various parts of the body simultaneously, including the spine, skull, pelvis, and ribs, and impacts approximately 6,000 people annually in England.
According to Cancer Research UK, only one-third of patients survive for ten years with this debilitating illness.
Approximately 6,000 people in England are diagnosed with multiple myeloma each year, but a cure is not yet available
Denial of responsibility! Vigour Times is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
Denial of responsibility! Vigour Times is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
